Widespread use of appetite-suppressing drugs could free up as much agricultural land as Italy by 2050 while preventing millions of deaths annually.
That is the projection of research by Roslyn Henry and Peter Alexander. The research models how glucagon-like peptide-1 receptor agonist medications, commonly known as GLP-1 drugs such as Ozempic and Wegovy, might ripple through the global food system as adoption scales.
About 100 million people already use GLP-1 weight-loss medications worldwide, according to data cited by The Conversation. Researchers tested scenarios ranging from concentrated use in high-income countries to widespread global access among adults living with obesity.
Under a scenario of widespread GLP-1 use alone, reduced calorie intake could prevent up to 6.6 million deaths each year by 2050. That shift would simultaneously free up 32 million hectares of agricultural land, a footprint slightly larger than Italy, according to Ars Technica.

The findings show even starker results when medication is paired with systemic dietary changes. Combining widespread GLP-1 adoption with a shift toward the EAT–Lancet diet could avoid up to 7 million deaths annually by 2050 and make approximately 46 million hectares of agricultural land available for other uses, as detailed in The Conversation.
Food demand ultimately dictates global agriculture, production, and trade. When individuals consume less food, producers adjust output accordingly, altering prices and land requirements across international borders.
These economic ripples mean that reduced demand from medication users can lower overall food prices. While cheaper food sounds beneficial, researchers caution that lower prices might encourage higher consumption among untreated populations, partially offsetting the intended health and environmental gains.
Obesity has historically been framed as a “lifestyle disease,” placing the burden entirely on individual willpower. Henry and Alexander argued that this framing ignores how diets are actually shaped by food availability, marketing, pricing, and store locations.
The UK government-commissioned national food strategy, finalized in 2021, highlighted that improving public diets requires changing the wider food environment rather than simply asking individuals to choose better. The study’s authors emphasize that GLP-1 medications should not become a technological fix that allows the broader food industry to escape scrutiny.
Instead, researchers advocate for combining pharmaceutical tools with policies that make nutritious food affordable and accessible while curbing the relentless promotion of unhealthy options.
Related reading
- EU, Others Reject Climate Deal in Turkey Over Fossil Fuel Omission
- Voyager 1 Reaches 1 Light-day From Earth, NASA Mission Manager Says
- Disinhibited Somatostatin Neurons in Resilient Male Mice Reverse Stress Transcriptomic Changes, Study Finds (archynewsy.com)
- Physicist Finds a Strange New Solution to Einstein's Equations in Five-Dimensional Spacetime: Black Saturn (newsylist.com)
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.